Therapeutic Asset Ratings

6,369 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type	Mayo Clinic	P2/3	B (63)
Alirocumab PCSK9 Inhibitor	Sun U. Kwon	P4	B (62)
Atezolizumab Liver Cancer	Niek Wijnen	P4	B (62)
DARATUMUMAB High Risk	The First Affiliated Hospital of Soochow University	P4	B (62)
DARATUMUMAB Newly Diagnosed	The First Affiliated Hospital of Soochow University	P4	B (62)
Emicizumab Adolescent	Kathelijn Fischer	P4	B (62)
Emicizumab Child	Kathelijn Fischer	P4	B (62)
Eptinezumab Migraine Associated Vertigo	Stanford University	P4	B (62)
Eptinezumab Tinnitus	Stanford University	P4	B (62)
Eptinezumab Vestibular Migraine	Stanford University	P4	B (62)
Fremanezumab Brain Disorder	Hospital Clínico Universitario de Valladolid	P4	B (62)
Fremanezumab Migraine With Aura	Hospital Clínico Universitario de Valladolid	P4	B (62)
Galcanezumab Migraine Associated Vertigo	Stanford University	P4	B (62)
Galcanezumab Tinnitus	Stanford University	P4	B (62)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER Heart Failure	AstraZeneca	P4	B (62)
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER Lymphoma	Peking University	P4	B (62)
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS IL17A (INTERLEUKIN 17A, IL-17A)), HOMO SAPIENS MONOCLONAL ANTIBODY Moderate-to-severe Plaque Psoriasis	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	P4	B (62)
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS IL17A (INTERLEUKIN 17A, IL-17A)), HOMO SAPIENS MONOCLONAL ANTIBODY Obesity Disorder	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	P4	B (62)
IMMUNOGLOBULIN G, ANTI-(HUMAN CALCITONIN GENE-RELATED PEPTIDE RECEPTOR) (HUMAN MONOCLONAL HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LIGHT CHAIN, DIMER Migraine Associated Vertigo	Stanford University	P4	B (62)
IMMUNOGLOBULIN G, ANTI-(HUMAN CALCITONIN GENE-RELATED PEPTIDE RECEPTOR) (HUMAN MONOCLONAL HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LIGHT CHAIN, DIMER Tinnitus	Stanford University	P4	B (62)
IMMUNOGLOBULIN G, ANTI-(HUMAN CALCITONIN GENE-RELATED PEPTIDE RECEPTOR) (HUMAN MONOCLONAL HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LIGHT CHAIN, DIMER Vestibular Migraine	Stanford University	P4	B (62)
Ipilimumab Surgery Programmed	Fondazione Policlinico Universitario Agostino Gemelli IRCCS	P4	B (62)
Pembrolizumab Glioblastoma	Jennifer Leddon	P4	B (62)
Atezolizumab Invasive Breast Carcinoma	Fondazione Michelangelo	P3	B (62)
Atezolizumab Renal Pelvis Urothelial Carcinoma	Alliance for Clinical Trials in Oncology	P3	B (62)

Showing 676 to 700 of 6,369 assets

PreviousPage 28 of 255Next